Biomarker-led trials to guide the future of precision psychiatry
As the neuroscience treatment landscape continuously evolves towards the wider use of precision treatment options, biomarker-led trials are emerging as…
02 Apr 2026
Podcast: the conflict in the Middle East’s impact on the medtech supply chain
On 28 February 2026, The US and Israel initiated a war with Iran. Since then, Iran has responded by closing the Strait of Hormuz, a waterway between the Persian Gulf…
31 Mar 2026
Non-invasive diagnostics in endometriosis: at the cusp of a turning point
Endometriosis affects an estimated 10% of reproductive-age women worldwide. Early diagnosis is crucial for preventing disease progression, improving pain management, and preserving fertility, yet long delays are common. In fact,…
30 Mar 2026
EU AI Act meets MDR/IVDR: clarity or chaos?
On 16 December 2025, the European Commission (EC) published a proposal that, if adopted, will harmonise artificial intelligence (AI) Act requirements for medical devices placed on the European market under…
10 Mar 2026
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched a widespread barrage of missiles and drones against the UAE…
06 Mar 2026
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has little interest in accolades. “I don’t care about winning awards…
23 Feb 2026
Podcast: Which pharma and medtech companies came out on top in 2025 revenues?
With the full-year 2025 earnings season coming to a close, certain sectors in healthcare performed strongly against the industry average. In the latest GlobalData Healthcare Podcast, pharmaceutical editor Robert Barrie…